Study of Cathepsin B inhibition in VEGFR TKI treated human renal cell carcinoma xenografts

Several therapeutic options are available for metastatic RCC, but responses are almost never complete, and resistance to therapy develops in the vast majority of patients. Consequently, novel treatments are needed to combat resistance to current therapies and to improve patient outcomes. We have app...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chun-Hau, Bhasin, Swati, Khanna, Prateek, Joshi, Mukta, Joslin, Patrick MN., Saxena, Ruchi, Amin, Seema, Liu, Suhu, Sindhu, Shreya, Walker, Sarah R., Catalano, Paul, Frank, David A., Alper, Seth L., Bhasin, Manoj, Bhatt, Rupal S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386754/
https://www.ncbi.nlm.nih.gov/pubmed/30796200
http://dx.doi.org/10.1038/s41389-019-0121-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386754/
https://www.ncbi.nlm.nih.gov/pubmed/30796200
http://dx.doi.org/10.1038/s41389-019-0121-7

Ejemplares similares